JP2004527489A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527489A5 JP2004527489A5 JP2002567272A JP2002567272A JP2004527489A5 JP 2004527489 A5 JP2004527489 A5 JP 2004527489A5 JP 2002567272 A JP2002567272 A JP 2002567272A JP 2002567272 A JP2002567272 A JP 2002567272A JP 2004527489 A5 JP2004527489 A5 JP 2004527489A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- oral pharmaceutical
- composition according
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 5
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 3
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 3
- 238000001179 sorption measurement Methods 0.000 claims 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000000813 small intestine Anatomy 0.000 claims 2
- 239000007962 solid dispersion Substances 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- -1 5-chloroindol-2-ylsulfonyl Chemical group 0.000 claims 1
- 229940123583 Factor Xa inhibitor Drugs 0.000 claims 1
- PSTBXECIKAJFMC-UHFFFAOYSA-N [4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-(4-pyridin-4-ylphenyl)methanone Chemical compound C1=CC2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=NC=C1 PSTBXECIKAJFMC-UHFFFAOYSA-N 0.000 claims 1
- DJBPJIZCEJIUJR-UHFFFAOYSA-N [4-[(5-chloro-1h-indol-2-yl)sulfonyl]piperazin-1-yl]-(4-imidazol-1-ylphenyl)methanone Chemical compound C=1C2=CC(Cl)=CC=C2NC=1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1N1C=CN=C1 DJBPJIZCEJIUJR-UHFFFAOYSA-N 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0104752.1A GB0104752D0 (en) | 2001-02-27 | 2001-02-27 | Pharmaceutical compositions |
| PCT/SE2002/000327 WO2002067904A1 (en) | 2001-02-27 | 2002-02-25 | Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004527489A JP2004527489A (ja) | 2004-09-09 |
| JP2004527489A5 true JP2004527489A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=9909545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567272A Pending JP2004527489A (ja) | 2001-02-27 | 2002-02-25 | フタル酸ヒドロキシプロピルメチルセルロースポリマーの固体分散物を含む医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040138231A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1365746A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004527489A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040011469A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1533268A (cg-RX-API-DMAC7.html) |
| BR (1) | BR0206960A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2435815A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0104752D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL156830A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03006746A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20033782D0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ527080A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002067904A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200305386B (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| WO2004105728A2 (en) * | 2003-05-27 | 2004-12-09 | Ranbaxy Laboratories Limited | Solid dispersions of cefpodoxime proxetil and processes for their preparation |
| KR100531612B1 (ko) * | 2003-08-12 | 2005-11-28 | 경동제약 주식회사 | 지속성 탐스로신 정제의 제조방법 및 그에 따른 지속성탐스로신 정제 |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| CA2720851A1 (en) * | 2008-04-15 | 2009-10-22 | Schering Corporation | Oral pharmaceutical compositions in a molecular solid dispersion |
| LT2346495T (lt) * | 2008-10-07 | 2016-10-10 | Astrazeneca Uk Limited | Farmacinė kompozicija 514 |
| US20170087134A1 (en) * | 2010-07-12 | 2017-03-30 | Salix Pharmaceuticals, Ltd | Formulations of rifaximin and uses thereof |
| CN104188893A (zh) * | 2014-08-18 | 2014-12-10 | 赵明亮 | 一种盐酸环丙沙星口服固体制剂及其制备工艺 |
| KR20240124428A (ko) | 2016-09-30 | 2024-08-16 | 샐릭스 파마슈티컬스 인코포레이티드 | 리팍시민의 고체 분산물 형태 |
| WO2025078941A1 (en) * | 2023-10-09 | 2025-04-17 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition of pirtobrutinib |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57120518A (en) * | 1981-01-19 | 1982-07-27 | Tanabe Seiyaku Co Ltd | Preparation of microcapsule |
| US5102668A (en) * | 1990-10-05 | 1992-04-07 | Kingaform Technology, Inc. | Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH |
| TW212139B (cg-RX-API-DMAC7.html) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
| WO1992018106A1 (fr) * | 1991-04-16 | 1992-10-29 | Nippon Shinyaku Co., Ltd. | Procede de production d'une dispersion solide |
| US6312726B1 (en) * | 1993-08-20 | 2001-11-06 | Nippon Shinyaku Co., Ltd. | Gastric remaining preparation, swollen molding, and production process |
| IL139406A (en) * | 1998-05-02 | 2004-07-25 | Astrazeneca Ab | Heterocyclic derivatives inhibiting factor XA, pharmaceutical preparations containing them and their use as a drug in the treatment of diseases or conditions mediated by factor XA in warm-blooded animals |
| AU782469B2 (en) * | 1999-12-23 | 2005-08-04 | Mayne Pharma International Pty Ltd | Improved pharmaceutical compositions for poorly soluble drugs |
-
2001
- 2001-02-27 GB GBGB0104752.1A patent/GB0104752D0/en not_active Ceased
-
2002
- 2002-02-25 IL IL15683002A patent/IL156830A0/xx unknown
- 2002-02-25 WO PCT/SE2002/000327 patent/WO2002067904A1/en not_active Ceased
- 2002-02-25 KR KR10-2003-7011174A patent/KR20040011469A/ko not_active Withdrawn
- 2002-02-25 EP EP02700946A patent/EP1365746A1/en not_active Withdrawn
- 2002-02-25 MX MXPA03006746A patent/MXPA03006746A/es unknown
- 2002-02-25 BR BR0206960-1A patent/BR0206960A/pt not_active IP Right Cessation
- 2002-02-25 NZ NZ527080A patent/NZ527080A/en unknown
- 2002-02-25 US US10/468,246 patent/US20040138231A1/en not_active Abandoned
- 2002-02-25 CN CNA028056256A patent/CN1533268A/zh active Pending
- 2002-02-25 CA CA002435815A patent/CA2435815A1/en not_active Abandoned
- 2002-02-25 JP JP2002567272A patent/JP2004527489A/ja active Pending
-
2003
- 2003-07-11 ZA ZA200305386A patent/ZA200305386B/en unknown
- 2003-08-26 NO NO20033782A patent/NO20033782D0/no not_active Application Discontinuation